US OptionsDetailed Quotes
KOD250117P10000
- 0.95
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.00High0.00Low
0.95Open0.95Pre Close0 Volume24 Open Interest10.00Strike Price0.00Turnover341.02%IV-8.77%PremiumJan 17, 2025Expiry Date1.68Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5897Delta0.1113Gamma3.33Leverage Ratio-0.1270Theta-0.0010Rho-1.96Eff Leverage0.0040Vega
Kodiak Sciences Stock Discussion
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...
NEWS
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
- 🇺🇸 U.S. stocks had their best week of 2023.
- 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%.
- 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January.
- 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%.
- 📉 Bond yields tempo...
No comment yet